The Profound System

The Profound system is a minimally invasive bipolar RF system with patented real-time temperature and impedance control.  It utilizes microneedles which are deployed into the reticular dermis or subcutaneous tissue, to precisely deliver fractionated injuries without thermal impact to the epidermis. Because of the proprietary real-time temperature feedback embedded in the Profound system, the optimal dermal temperature can be reached and maintained in any skin impedance conditions.  During dermal treatments, the deep dermis is targeted, this is where the concentration of collagen is the highest. The thermal injury stimulates a wound healing response which naturally creates new elastin, collagen, and hyaluronic acid formation. This dermal remodeling results in visible skin improvement. Additionally, during cellulite treatments, when the subcutaneous tissue is targeted, the fractionated injuries will increase dermal thickness, remodels septae, and decrease adipose volume.

​

• The Profound treatment is the only RF Microneedling treatment that stimulates and triggers the creation of NEW ELASTIN, Collagen and Hyaluronic Acid. 
   

• CLINICALLY PROVEN in 8 comprehensive clinical studies to create 5x more ELASTIN
   

• A single treatment brings the snap back to aging, sagging skin  

• 100% response rate for facial wrinkles
   

• 94% of treated thighs showed improvement in cellulite appearance

 

Who is the ideal patient
for the Profound treatment?

Treatment with the Profound system is a completely customizable and minimally invasive treatment suitable for women and men who wish to target the key signs of aging and cellulite on the body. The ideal patient is someone who suffers from loss of vital skin elements due to genetics, maturation, and other environmental factors resulting in overall volume reduction, wrinkles, and decreased elasticity. This is a procedure for patients who are looking to improve wrinkles and cellulite with minimal downtime.  In published studies, Profound demonstrated high clinical response rates given the consistency of reaching optimal temperature endpoints.  Dermal treatments yielded a 100% clinical response rate for rhytids.  In the cellulite study design, 94% of patients obtained ≥ 1-point improvement in cellulite appearance at 3 months post-treatment.  The Profound system is designed to generate treatment lesions in the reticular dermis.  Therefore, wrinkles with reticular dermal involvement, including wrinkles associated with intrinsic aging, may be most amenable to treatment.

 

What should a patient
expect post treatment?

Immediately post-treatment the treated area will appear edematous (swollen) and erythematous (red). Pin-point ecchymosis from microneedle insertions will be observed and purpura (bruising) may be noticed from the local anesthesia injection points. Immediately following treatment, ice compress with barrier should be used for the first 30 - 45 minutes. For next 24 hours, patient can opt to continue with cold compress at 20 minutes on - 20 minutes off intervals every 2 hours for comfort. It is recommended to sleep with head elevated for the first 2 - 3 nights post Profound treatment (for facial/neck treatments). Erythema (redness) typically resolves within 1 - 2 days of treatment. Edema and purpura will typically resolve within 5 - 7 days post treatment

This treatment is a one-time treatment but results can take up to 12 months for full effect.  Largest amount of improvement generally seen at 3-6 months post treatment.  

 

Contraindications for this procedure:

• Pacemaker or internal defibrillator.

• Active skin infection(s).

• Collagen vascular disease.

• Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, ay

• be treated only following a prophylactic regimen.

• Any active condition in the treatment area, such as sores, Psoriasis, eczema, and rash.

• History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile skin.

• History of bleeding coagulopathies or use of anticoagulants.

• History of hypertrophic scarring.

• Facial laser resurfacing and deep chemical peeling within the last three months.

• Any surgical procedure in the treatment area within the last three months or before complete healing.

• Isotretinoin (Accutane) use in the previous 12 months.